MYHEP ALL contains Sofosbuvir (NS5B polymerase inhibitor) and Velpatasvir (NS5A inhibitor), which together block the replication of the hepatitis C virus at multiple stages.
Recommended for:
Treatment of chronic hepatitis C infection (HCV) in adults of all six genotypes
Take one tablet orally once daily, with or without food. The typical treatment duration is 12 weeks, as directed by a healthcare provider.
Contraindications:
Side Effects: